SYMBIO PHARMACEUTICALS LTD revenue for the last year amounted to 5.59 B JPY, the most of which — 5.59 B JPY — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 10.01 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought SYMBIO PHARMACEUTICALS LTD 5.59 B JPY, and the year before that — 10.01 B JPY.